Cointime

Abreos Biosciences

company

About

Abreos Biosciences develops lateral flow assays that measure the activity of high value biologics.

  • 1 - 10

Highlights

Total Funding Amount
$1.92M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Seed
Last Funding Money Raised
$725K
Industries
Biotechnology,Clinical Trials,Medical
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Abreos Biosciences develops lateral flow assays that measure the activity of high-value biologics. Its simple devices can be used for quality assurance, pharmacokinetic monitoring, and authentication in field, forensic, or point of care settings. We deliver value by enhancing brand protection, improving patients’ outcomes, and enabling rapid authentication for counterfeit prevention and end-user confidence.

The company was founded in 2013 and headquartered in San Diego, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.92M
Abreos Biosciences has raised a total of $1.92M in funding over 2 rounds. Their latest funding was raised on Jun 5, 2017 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 5, 2017 Debt Financing $1.20M 1 — — Detail
Jul 13, 2016 Seed $725K 1 Triton Technology Fund — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Abreos Biosciences is funded by 1 investors. Triton Technology Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Triton Technology Fund — Debt Financing
Cointime
Chủ Đề
Công Ty